IMMUPHARMA
ImmuPharma focuses in developing pioneering and novel drugs in specialist therapeutic areas where there is a distinct lack of existing treatments, avoiding primary care (diseases treated by GPs) where many treatments exist. This is consistent with the trends in the pharmaceutical industry. Since our foundation, our research strategy has been to work closely with the largest fundamental research organisation in Europe, the Centre National de la Recherche Scientifique, (CNRS) in France. This collaboration enables us to access innovative research with substantial embedded value at a relatively low cost, and to work with many leading scientists and doctors. ImmuPharma has exclusive rights to all its intellectual property assets.
IMMUPHARMA
Industry:
Biotechnology Developer Tools Life Science Pharmaceutical
Founded:
1999-01-01
Address:
Westminster, Westminster, United Kingdom
Country:
United Kingdom
Website Url:
http://www.immupharma.co.uk
Total Employee:
1+
Status:
Active
Contact:
(442) 071-5240
Email Addresses:
[email protected]
Total Funding:
12.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
OMass Technologies
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Founder
Stock Details
Investors List
Lanstead Capital
Lanstead Capital investment in Post-IPO Equity - ImmuPharma
Official Site Inspections
http://www.immupharma.co.uk Semrush global rank: 2.19 M Semrush visits lastest month: 8.96 K
- Host name: 217-160-0-252.elastic-ssl.ui-r.com
- IP address: 217.160.0.252
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "ImmuPharma"
About Us - ImmuPharma PLC
ImmuPharma PLC is an AIM listed (LSE:IMM) evolving speciality pharma company headquartered in London with its research R&D team, ImmuPharma Biotech, based in France Our research strategy is based on two strategic …See details»
Corporate Governance - ImmuPharma PLC
ImmuPharma is an ethical organisation with the vision to develop novel drugs to treat serious medical conditions, delivering value to patients, medical professionals, healthcare payers and …See details»
IMMUPHARMA PLC overview - Find and update company …
GOV.UK Find and update company information Companies House does not verify the accuracy of the information filed (link opens a new window) ... Charges for IMMUPHARMA PLC …See details»
ImmuPharma - Crunchbase Company Profile & Funding
Work closely with the largest fundamental research organisation in Europe, the Centre National de la Recherche Scientifique, (CNRS) in France. This collaboration enables us to access …See details»
Corporate Update - ImmuPharma PLC
Corporate Update 29th September 2021 - 11:41 am. ImmuPharma PLC (LSE:IMM; Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company, is pleased …See details»
IMMUPHARMA PLC - Companies House
Company Overview for IMMUPHARMA PLC (03929567) Filing history for IMMUPHARMA PLC (03929567) People for IMMUPHARMA PLC (03929567) Charges for IMMUPHARMA PLC …See details»
Immupharma Plc - Company Profile - Endole
Feb 21, 2000 Immupharma Plc is an active company located in . View company profile, shareholders, contacts, financials, industry and description. ... Immupharma.co.uk. See All …See details»
IMMUPHARMA PLC Company Profile - Dun & Bradstreet
IMMUPHARMA PLC Company Profile | LONDON, United Kingdom | Competitors, Financials & Contacts - Dun & Bradstreet Find company research, competitor information, contact details & …See details»
ImmuPharma PLC, IMM:LSE profile - FT.com - Financial Times
Nov 7, 2024 ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company is focused on developing peptide bio …See details»
ImmuPharma - VentureRadar
Mar 25, 2020 "ImmuPharma is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s …See details»
ImmuPharma plc (AIM: IMM) Company Profile & Overview
Nov 21, 2024 ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom. ImmuPharma plc. Country: ... Timothy McCarthy: Contact Details. Address: 1 Bartholomew Close London, EC1A 7BL United Kingdom. Phone: 44 20 7206 2650: Website: immupharma.co.uk: Stock Details. Ticker Symbol: IMM: Exchange: London Stock Exchange …See details»
CORPORATE UPDATE – The Evolution of ImmuPharma
Nov 18, 2021 ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is pleased to present a comprehensive and detailed update of the significant …See details»
Immupharma Plc Company Profile - Overview - GlobalData
ImmuPharma is headquartered in London, the UK. ... Website www.immupharma.co.uk Telephone 44 20 72062650. No of Employees 5. Industry Pharmaceuticals and Healthcare. …See details»
Immupharma Company Profile 2024: Stock Performance
Immupharma General Information Description. ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based …See details»
ImmuPharma - Overview, News & Similar companies
Dec 20, 2021 ImmuPharma contact info: Phone number: +44 2072062650 Website: www.immupharma.co.uk What does ImmuPharma do? Founded in 1999, ImmuPharma a …See details»
ImmuPharma Company Profile - Office Locations, Competitors
Oct 29, 2024 ImmuPharma is a pharmaceutical company focused on developing innovative drugs to treat serious medical conditions in specialist therapeutic areas. Its low risk-strategy is …See details»
ImmuPharma PLC Company Profile | IMM | GB0033711010 | Fidelity
Oct 25, 2024 Find the latest ImmuPharma PLC (IMM | GB0033711010) company profile plus latest price, trades, performance, company information and news. ImmuPharma PLC (IMM) ... MI Chelverton UK Equity Growth Fund: 21,324,433: Director dealings. Date. chevron-l-regular. chevron-r-regular. Action; No data:See details»
ImmuPharma PLC Key Statistics | IMM | GB0033711010GBP | Fidelity
6 days ago ImmuPharma PLC is a drug discovery and development company. The company along with its subsidiaries is engaged in the research and development of novel drugs based …See details»
Immupharma plc Announces Appointment of Ashley Clarke as …
2 days ago ImmuPharma plc to confirm the appointment of Ashley Clarke ACA, as Company Secretary to the Company. The appointment is with immediate effect. Ashley has been closely …See details»
Our Team - ImmuPharma PLC
Laura Mauran-Ambrosino Ph.D. Chief Scientific Officer of ImmuPharma Biotech. Born in Montpellier, France, Dr Mauran- Ambrosino obtained her PhD in Chemistry<br /> at the …See details»